✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (238 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
37.81
3,92,135
69.92
1,61,246
23.40
1,26,185
59.93
1,19,979
19.26
1,09,418
55.98
1,05,955
22.75
1,04,040
25.02
92,573
45.76
66,457
28.65
65,464
18.77
63,656
77.30
58,258
107
48,487
94.57
48,120
124
48,071
48.83
46,399
137
35,146
42.87
33,377
42.88
33,025
34.28
31,877
276
27,090
38.53
26,397
34.49
25,666
-
25,178
29.41
23,780
123
22,711
57.30
22,179
-
21,174
118
20,827
57.23
20,464
31.70
19,116
110
18,769
31.63
17,873
38.50
17,716
48.19
17,162
9.08
15,420
32.26
14,047
166
13,870
27.67
13,269
60.56
12,112
33.63
12,060
63.70
12,043
28.02
11,581
23.27
11,532
34.93
10,500
56.70
10,111
31.07
8,279
23.23
8,134
22.39
8,125
72.58
8,064
28.36
7,631
21.70
7,409
30.28
5,392
-
5,147
38.27
4,968
162
4,809
24.89
4,700
-
4,486
42.20
4,398
94.15
4,199
21.69
3,964
46.13
3,931
27.96
3,827
58.92
3,645
27.17
3,555
49.26
3,478
32.32
3,394
53.20
3,367
133
3,284
54.20
3,174
31.95
2,959
38.15
2,791
241
2,775
-
2,766
8.70
2,753
40.33
2,199
31.72
2,067
60.73
1,929
43.33
1,838
46.27
1,740
29.79
1,715
26.99
1,703
27.04
1,645
15.20
1,621
29.33
1,381
129
1,315
-
1,139
56.18
1,127
12.94
1,117
9.86
1,030
23.54
1,022
-
931
19.24
888
3.73
864
19.68
846
24.21
845
40.09
837
38.38
758
33.45
731
44.80
715
34.20
702
37.07
700
22.68
635
18.99
628
11.19
601
25.18
590
-
578
24.81
550
51.79
544
15.13
491
-
477
49.04
466
72.56
457
33.78
452
-
452
64.63
401
46.22
376
-
374
39.57
372
38.02
365
21.10
364
47.52
357
27.63
325
61.49
323
31.08
321
37.45
310
18.18
306
67.30
287
35.27
286
-
258
-
253
25.68
252
10.12
246
122
245
25.55
244
18.55
238
-
199
7.60
199
47.55
198
-
195
14.08
190
10.39
186
34.18
183
-
174
660
171
38.96
171
17.24
166
47.92
163
14.99
162
11.72
159
393
157
211
148
12.16
147
20.03
143
9.42
143
16.06
136
16.86
135
33.85
126
11.72
126
-
119
11.87
114
27.37
103
913
101
20.95
101
14.90
99
16.93
97
-
95
17.93
89
28.62
89
20.06
87
9.89
84
9.38
84
23.09
78
73.09
76
10.42
71
25.22
71
160
69
-
66
17.49
66
14.57
61
-
60
48.48
54
7.05
51
11.49
48
30.81
48
-
47
44.95
46
13.48
45
10.83
45
-
44
20.73
42
95.31
42
54.88
40
-
40
12.18
40
39.40
39
14.51
38
16.16
38
72.59
37
-
36
12.59
35
156
35
58.42
34
-
33
38.74
33
-
30
30.30
29
-
27
145
26
84.34
25
11.30
23
-
23
22.93
23
51.91
21
18.28
19
-
18
-
18
-
17
-
17
-
13
118
12
50.94
12
-
11
41.87
11
-
11
21.30
10
-
10
-
9
966
9
110
9
275
8
-
6
87.72
5
-
5
-
5
-
4
44.49
4
-
2
Showing 5 238 of 238 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Timeline
        Watchlist
        Portfolio
        Alerts
        Research
        Stock Screener
        Market
        Raw Material